1. Home
  2. Analysis
  3. Carbamazepine
  4. Learning-disorder

Carbamazepine and Learning disorder - a phase IV clinical study of FDA data

Summary:

Learning disorder is reported as a side effect among people who take Carbamazepine (carbamazepine), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Valproate Sodium, and have Seizures.

The phase IV clinical study analyzes which people have Learning disorder when taking Carbamazepine. It is created by eHealthMe based on reports of 43,715 people who have side effects when taking Carbamazepine from the FDA, and is updated regularly.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.

What is Learning disorder?

Learning disorder (the brain's disability to receive, process, store, respond to and communicate information) is found to be associated with 146 drugs and 223 conditions by eHealthMe. Check the latest studies of Learning disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

43,715 people reported to have side effects when taking Carbamazepine.
Among them, 27 people (0.06%) have Learning disorder.

Could Carbamazepine cause Learning disorder?

Among these 27 people:

How long have people been on Carbamazepine when they have Learning disorder? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Learning disorder when taking Carbamazepine? *

  • female: 61.54 %
  • male: 38.46 %

What is the age of people who have Learning disorder when taking Carbamazepine? *

  • 0-1: 0.0 %
  • 2-9: 11.11 %
  • 10-19: 33.33 %
  • 20-29: 0.0 %
  • 30-39: 50.0 %
  • 40-49: 5.56 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Carbamazepine? *

  1. Valproate Sodium: 4 people, 14.81%
  2. Tegretol: 2 people, 7.41%
  3. Keppra: 2 people, 7.41%
  4. Valproic Acid: 1 person, 3.70%
  5. Phenytoin: 1 person, 3.70%
  6. Folic Acid: 1 person, 3.70%
  7. Ethosuximide: 1 person, 3.70%
  8. Dilantin: 1 person, 3.70%
  9. Depakene: 1 person, 3.70%

What are other side effects people have besides Learning disorder? *

  1. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 10 people, 37.04%
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 9 people, 33.33%
  3. Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 7 people, 25.93%
  4. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 5 people, 18.52%
  5. Disturbance In Attention: 5 people, 18.52%
  6. Petit Mal Epilepsy (absence seizure): 5 people, 18.52%
  7. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 5 people, 18.52%
  8. Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 5 people, 18.52%
  9. Muscle Aches (muscle pain): 5 people, 18.52%
  10. Dementia (madness): 5 people, 18.52%

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 33.33%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 22.22%
  3. Drug Exposure During Pregnancy: 3 people, 11.11%
  4. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 7.41%
  5. Petit Mal Epilepsy (absence seizure): 1 person, 3.70%
  6. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Carbamazepine and have Learning disorder?

- Check whether Learning disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbamazepine:

Learning disorder treatments and more:

How severe was Learning disorder and when was it recovered:

Expand to all the drugs that have ingredients of carbamazepine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Learning disorder:

Browse all the conditions that are associated with Learning disorder:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbamazepine) and Carbamazepine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.